Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic (Record no. 27274573)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02429 a2200685 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517160647.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201805s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1557-3265 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1158/1078-0432.CCR-16-2923 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Delord, Jean-Pierre |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180511 |
| 245 00 - TITLE STATEMENT | |
| Title | Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Date of publication, distribution, etc. | Sep 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 5339-5348 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carbamates |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Models, Animal |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Evaluation, Preclinical |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Monitoring |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kaplan-Meier Estimate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Maximum Tolerated Dose |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Melanoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Molecular Targeted Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Staging |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Kinase Inhibitors |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proto-Oncogene Proteins B-raf |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sulfonamides |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Robert, Caroline |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nyakas, Marta |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McArthur, Grant A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kudchakar, Ragini |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mahipal, Amit |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yamada, Yasuhide |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sullivan, Ryan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Arance, Ana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kefford, Richard F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Carlino, Matteo S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hidalgo, Manuel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gomez-Roca, Carlos |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Michel, Daniela |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Seroutou, Abdelkader |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aslanis, Vassilios |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Caponigro, Giordano |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stuart, Darrin D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moutouh-de Parseval, Laure |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Demuth, Tim |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dummer, Reinhard |
| 773 0# - HOST ITEM ENTRY | |
| Title | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Related parts | vol. 23 |
| -- | no. 18 |
| -- | p. 5339-5348 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1158/1078-0432.CCR-16-2923">https://doi.org/10.1158/1078-0432.CCR-16-2923</a> |
| Public note | Available from publisher's website |
No items available.